It's Catalyst vs. the feds as tiny drugmaker sues FDA over 'capricious' approval for rival
admin 12th June 2019 Uncategorised 0Catalyst isn’t shying away from controversy. The company that made headlines for its $375,000 price on a long-available drug has now sued the FDA for approving a potential competitor.
More: It's Catalyst vs. the feds as tiny drugmaker sues FDA over 'capricious' approval for rival
Source: fierce